Mapping of radiation oncology and gynecologic oncology services available to treat the growing burden of cervical cancer in Africa.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
16 Nov 2023
Historique:
received: 15 04 2023
revised: 09 09 2023
accepted: 22 10 2023
medline: 19 11 2023
pubmed: 19 11 2023
entrez: 18 11 2023
Statut: aheadofprint

Résumé

To meet the demand for cervical cancer care in Africa, access to surgical and radiotherapy services need to be understood. We thus mapped the availability of gynecologic and radiotherapy equipment and staffing for treating cervical cancer. We collected data on gynecologic and radiation oncology staffing, equipment, and infrastructure capacities across Africa. Data was obtained from February to July 2021 through collaboration with international partners using REDCap. Cancer incidence was taken from the International Agency for Research on Cancer's GLOBOCAN 2020 database. Treatment capacity, including the numbers of radiation oncologists, radiation therapists, physicists, gynecologic oncologists, and hospitals performing gynecologic surgeries was calculated per 1000 cervical cancer cases. Adequate capacity was defined as two radiation oncologists and two gynecologic oncologists per 1000 cervical cancer cases. Forty-three of 54 (79.6%%) African countries responded, and data were not reported for 11 (20.4%) countries. Respondents from 31 (57.4%) countries reported access to specialist gynecologic oncology services, but staffing was adequate in only 11(20.4%) countries. Six (11%) countries reported that generalist obstetrician-gynecologists perform radical hysterectomies. Radiation oncologist access was available in 39 (72.2%) countries, but staffing was adequate in only 16 (29.6%) countries. Six (11%) countries had adequate staffing for both gynecologic and radiation oncology; seven (13%) countries had no radiation or gynecologic oncologist. Access to external beam radiation was available in 31 (57.4%) countries, and access to brachytherapy was available in 25 (46.3%) countries. The number of countries with training programs in gynecologic oncology, radiation oncology, medical physics, and radiation therapy were 14 (26%), 16 (30%), 11 (20%), and 17 (31%), respectively. We identified areas needing comprehensive cervical cancer care infrastructure, human resources, and training programs. There are major gaps in access to radiation oncologists and trained gynecologic oncologists in Africa.

Identifiants

pubmed: 37979709
pii: S0360-3016(23)08043-4
doi: 10.1016/j.ijrobp.2023.10.036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Chidinma Anakwenze Akinfenwa (CA)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America.

Emma Allanson (E)

Division of Obstetrics & Gynecology, King Edward Memorial Hospital for Women, Subiaco, Australia; Institute for Health Research, University of Notre Dame, Fremantle, Australia. Electronic address: emmaallanson@gmail.com.

Agnes Ewongwo (A)

Stanford Cancer Institute, Palo Alto, United States of America.

Christian Lumley (C)

Office of Global Health, University of Texas Southwestern Medical Center, Dallas, United States of America.

Lisa Bazzett-Matabele (L)

Department of Obstetrics & Gynecology, University of Botswana, Gaborone, Botswana; Department of Obstetrics & Gynecology, Yale University School of Medicine, New Haven, United States of America.

Susan C Msadabwe (SC)

Cancer Diseases Hospital, Lusaka, Zambia.

Paul Kamfwa (P)

Gynecologic Oncology Unit, Cancer Diseases Hospital, Lusaka, Zambia.

Tarek Shouman (T)

National Cancer Institute of Egypt, Cairo, Egypt.

Dorothy Lombe (D)

Cancer Screening, Treatment and Support Cluster, Health New Zealand, Palmerston North, New Zealand.

Fidel Rubagumya (F)

Rwanda Military Hospital, Kigali, Rwanda; Division of Cancer Care and Epidemiology and Department of Oncology, Queen's University, Kingston, Canada.

Alfredo Polo (A)

Applied Radiation Biology and Radiotherapy Section, Division of Human Health, Department of Nuclear Sciences & Applications, International Atomic Energy Agency, Vienna, Austria.

Atara Ntekim (A)

Department of Radiation Oncology, University of Ibadan, Ibadan, Nigeria.

Verna Vanderpuye (V)

National Center for Radiotherapy, Oncology, and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana.

Rahel Ghebre (R)

Department of Obstetrics, Gynecology, and Women's Health and Masonic Cancer Center, University of Minnesota, Minneapolis, United States of America.

Lofti Kochbati (L)

Department of Radiotherapy, Abderrahmen Mami Hospital, Tunis, Tunisia.

Munir Awol (M)

Department of Oncology, Addis Ababa University, Addis Ababa, Ethiopia.

Freddy Houéhanou Rodrigue Gnangnon (FHR)

Department of Visceral Surgery, National Teaching Hospital of Cotonou, Cotonou, Benin; Department of Epidemiology of Chronic Diseases in The Tropical Zone, Institute of Epidemiology and Tropical Neurology, Limoges, France; Laboratory of Epidemiology of Chronic and Neurological Diseases, University of Abomey-Calavi, Cotonou, Benin.

Leon Snyman (L)

Department Obstetrics & Gynaecology, University of Pretoria, Pretoria, South Africa.

Joël Fokom Domgue (JF)

Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, The United States of America; Faculty of Medicine and Biomedical Sciences, Department of Obstetrics and Gynecology, University of Yaoundé, Yaoundé, Cameroon.

Luca Incrocci (L)

Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

Ntokozo Ndlovu (N)

Department of Oncology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe; Department of Radiotherapy and Oncology, Parirenyatwa Hospital, Harare, Zimbabwe.

Malala Razakanaivo (M)

Department of Radiotherapy, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo, Madagascar.

May Abdel-Wahab (M)

Division of Human Health, Department of Nuclear Sciences & Applications, International Atomic Energy Agency, Vienna, Austria.

Edward Trimble (E)

National Cancer Institute, Bethesda, United States of America.

Kathleen Schmeler (K)

Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States of America.

Hannah Simonds (H)

Department of Radiation Oncology, Stellenbosch University, Cape Town, South Africa; Department of Oncology, University Hospitals Plymouth Trust, Plymouth, United Kingdom.

Surbhi Grover (S)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States of America. Electronic address: surbhi.grover@pennmedicine.upenn.edu.

Classifications MeSH